Li Li is a Chinese businessman, the self-made billionaire Founder and Executive Chairman of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE: 002394), a global leader in the manufacture and export of heparin (an anti-coagulant drug). His career is rooted in pharmaceuticals and biochemistry.

Li's career began humbly as a pharmaceutical worker in Shenzhen. He founded Hepalink in 1994 with his wife, Li Tan, recognizing the immense, untapped domestic and international demand for high-quality heparin (a life-saving drug often sourced from China). His philosophy centers on scale manufacturing, technological precision, and vertical integration across the drug supply chain.

• Shenzhen Hepalink Pharmaceutical (Founder & Executive Chairman): The core publicly traded asset, a global leader in heparin and bio-pharmaceuticals (exporting heparin to over 40 countries).
• Pharmaceutical Focus: His success is built on scale manufacturing and dominating the supply of heparin and related APIs.
• Investment Strategy: His philosophy is rooted in long-term investment in biochemistry and pharmaceutical R&D and catering to the massive global healthcare supply chain.

Li Li's strategic genius was his commitment to quality control in the highly specialized heparin manufacturing process. Under his leadership as Chairman, Hepalink grew exponentially, successfully executing its IPO on the Shenzhen Stock Exchange and becoming the largest heparin manufacturer and exporter in China. His structural contribution is immense: providing a foundational supply of heparin for the global pharmaceutical industry.

His wealth is secured by the colossal, long-term, stable profitability of the global specialty pharmaceutical sector. He and his wife maintain a controlling stake in the publicly traded company, ensuring the long-term focus on biomedical R&D.

Li Li's social impact is structural, stemming from Hepalink's role in providing essential, life-saving medicines (heparin) to millions of patients globally. The company contributes significantly to global public health and the stability of the pharmaceutical supply chain. His personal philanthropy supports various community and educational initiatives.

His structural contribution is tied to the successful industrialization and scale of the Chinese specialized pharmaceutical manufacturing sector.

Li Li maintains the professional, pragmatic style of a Chinese industrial executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the specialized pharmaceutical sector.

Residing in Shenzhen, China, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, quality control, and the long-term, stable growth of the healthcare supply chain.